October 7 - 9, 2021 Geneva (Switzerland)
PO1-001 | Evaluation of efficacy and safety of splenic artery embolization versus endoscopic treatment for secondary prophylaxis of variceal bleedings | Sergii Kozlov | Received |
PO2-001 | Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukaemia | Federico Ravaioli | Received |
PO6-001 | Upper gastrointestinal bleding in cirrhosis: predictive factors of recurence | Fatma Ben Farhat | Received |
PO5-001 | The efficacies and risks comparisons between direct oral anticoagulants and low molecular weight heparin or warfarin in both cirrhotic and non-cirrhotic portal vein thrombosis patients: systematic review and meta-analysis | Boby Pratama Putra | Received |
PO4-001 | Prevalence and associated factors of ascitic decompensation in patients with acute variceal bleeding | Myriam Ayari | Received |
PO8-001 | A non-invasive diagnosis of oesophageal varices in patients with compensated liver cirrhosis | AbdelGhani Atef Abdel Ghani Badran | Received |
PO7-001 | Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure | Alberto Zanetto | Received |
PO4-002 | Liver fibrosis markers as predictors of recurrent variceal bleeding in cirrhosis | Fatma Ben Farhat | Received |
PO7-002 | Natural history and clinical impact of non-neoplastic portal vein thrombosis in cirrhotics with hepatocellular carcinoma | SARAH SHALABY | Received |
PO8-002 | The associations among von willebrand factor, ADAMTS13, and factor VIII with non-malignant portal vein thrombosis incidence: systematic review and meta-analysis | Boby Pratama Putra | Received |
PO3-002 | Non-cirrhotic portal hypertension in people living with HIV infection: significant progression to end stage liver disease | Kate Childs | Received |
PO5-002 | Improvement in portal vein thrombosis clot volume is associated with improved overall survival in cirrhosis patients with PVT: A justification for treatment? | Lauren Carlini | Received |
PO1-002 | Portal vein thrombosis is not associated with increased mortality or excess decompensation in cirrhosis patients: A case control study | Lauren Carlini | Received |
PO2-002 | A rare cause of acute liver failure associated with acquired thrombophilia | ZANIL YOONUS NIZAR | Received |
PO6-002 | Thrombophilia profile in patients with extrahepatic portal vein obstruction (EHPVO) | Akash Shukla | Received |
PO3-003 | Non-cirrhotic portal hypertension in a patient with protein C and S deficiency. A case report | Faisal Nawaz | Received |
PO1-003 | Performance of ten non-invasive liver function tests in predicting six-week mortality in acute variceal bleeding | Nouha Trad | Received |
PO6-003 | Impact of prothrombin and factor V leiden mutations on the progression of fibrosis in patients with chronic hepatitis C | Eman Abdelsameea | Received |
PO7-003 | Invasive and non-invasive staging of Fontan-associated liver disease: The VALDIG prospective Fonliver cohort | Luis Téllez | Received |
PO5-003 | Impact of asymptomatic superior mesenteric vein thrombosis on the survival of patients with liver cirrhosis | Le Wang | Received |
PO4-003 | Association of C-type lectin-like receptor 2 and galectin-1 with portal venous system thrombosis in liver cirrhosis | shixue xu | Received |
PO2-003 | Prediction of esophageal variceal rebleeding in cirrhosis using the P2/MS noninvasive index based on complete blood counts | Fatma Ben Farhat | Received |
PO4-004 | Performance of albumin, bilirubin and platelets criteria to predict the absence of high-risk esophageal varices | Nouha Trad | Received |
PO8-004 | Portosinusoidal vascular disease and Common variable immunodeficiency | Berta Bartrolí Alabau | Received |
PO5-004 | Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study | Bernhard Scheiner | Received |
PO3-004 | Red cell distribution width as a predictor of outcome in hospitalized cirrhotic patients | Mohamed Abdel-Samiee | Received |
PO1-004 | The peculiarities of the management of a patient with ischemic stroke in Rendu-Osler-Weber disease | Antonina Antonenko | Received |
PO7-004 | High plasma thrombomodulin level indicated poor prognostic of liver cirrhosis: A prospective cohort study | Jing Zhang | Received |
PO6-004 | Divergencies in macrophage activation markers soluble CD163 and mannose receptor in patients with non-cirrhotic and cirrhotic portal hypertension | Henning Grnbk | Received |
PO2-005 | Assessing the bleeding risk after liver biopsy using new clinical and biological tools : a prospective analysis of 306 procedures | alix riescher | Received |
PO4-005 | Performance of bleeding risk scores in predicting mortality in acute variceal bleeding | Nouha Trad | Received |
PO8-005 | Potential role of cellular component of blood in ADP induced platelet aggregation | Dermot Cox | Received |
PO5-005 | Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease | Katharina Pomej | Received |
PO7-005 | Impact of porto-systemic vein shunting on non-alcoholic liver disease and hepatocellular carcinoma development in a high fat diet mouse model | Andrea Peloso | Received |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|